In Vitro Evaluation of In Silico Screening Approaches in Search for Selective ACE2 Binding Chemical Probes

被引:1
|
作者
Rayevsky, Alexey, V [1 ,2 ]
Poturai, Andrii S. [1 ]
Kravets, Iryna O. [1 ,3 ]
Pashenko, Alexander E. [1 ,4 ,5 ]
Borisova, Tatiana A. [6 ]
Tolstanova, Ganna M. [4 ]
Volochnyuk, Dmitriy M. [1 ,3 ,4 ]
Borysko, Petro O. [1 ]
Vadzyuk, Olga B. [1 ]
Alieksieieva, Diana O. [1 ]
Zabolotna, Yuliana [7 ]
Klimchuk, Olga [7 ]
Horvath, Dragos [7 ]
Marcou, Gilles [7 ]
Ryabukhin, Sergey, V [1 ,4 ,5 ]
Varnek, Alexandre [7 ]
机构
[1] Enamine Ltd, 78 Chervonotkatska St, UA-02660 Kiev, Ukraine
[2] Natl Acad Sci Ukraine, Inst Food Biotechnol & Genom, 2a Osipovskogo St, UA-04123 Kiev, Ukraine
[3] Chemspace LLC, 85 Chervonotkatska St, UA-02094 Kiev, Ukraine
[4] Taras Shevchenko Natl Univ Kyiv, Educ & Sci Inst High Technol, 60 Volodymyrska St, UA-01033 Kiev, Ukraine
[5] Natl Acad Sci Ukraine, Inst Organ Chem, 5 Murmanska St, UA-03028 Kiev, Ukraine
[6] Natl Acad Sci Ukraine, Palladin Inst Biochem, 9 Leontovitcha St, UA-01054 Kiev, Ukraine
[7] Univ Strasbourg, Lab Chemoinformat, 4 Rue B Pascal, F-67081 Strasbourg, France
来源
MOLECULES | 2022年 / 27卷 / 17期
基金
新加坡国家研究基金会;
关键词
QSAR modeling; molecular docking; Neprilysin; angiotensin-converting enzyme; selective ACE2 enzyme binding; blood-brain barrier penetration; enzymology inhibition assay adjustment; in vitro studies; DOCKING; ICM; ARCHITECTURE; INHIBITORS; PLATFORM; DESIGN; POTENT; DOMAIN;
D O I
10.3390/molecules27175400
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
New models for ACE2 receptor binding, based on QSAR and docking algorithms were developed, using XRD structural data and ChEMBL 26 database hits as training sets. The selectivity of the potential ACE2-binding ligands towards Neprilysin (NEP) and ACE was evaluated. The Enamine screening collection (3.2 million compounds) was virtually screened according to the above models, in order to find possible ACE2-chemical probes, useful for the study of SARS-CoV2-induced neurological disorders. An enzymology inhibition assay for ACE2 was optimized, and the combined diversified set of predicted selective ACE2-binding molecules from QSAR modeling, docking, and ultrafast docking was screened in vitro. The in vitro hits included two novel chemotypes suitable for further optimization.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Rational approaches to discover SARS-CoV-2/ACE2 interaction inhibitors: Pharmacophore-based virtual screening, molecular docking, molecular dynamics and binding free energy studies
    Yazdani, Mohsen
    Jafari, Ameneh
    Mahdian, Soodeh
    Namazi, Mohsen
    Gharaghani, Sajjad
    [J]. JOURNAL OF MOLECULAR LIQUIDS, 2023, 375
  • [42] Quantum chemical studies on the binding domain of SARS-CoV-2 S-protein: human ACE2 interface complex
    Haritha, Mambatta
    Suresh, Cherumuttathu H.
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (15): : 7354 - 7364
  • [43] Chemical Composition and Pharmacological Evaluation and of Toddalia asiatica (Rutaceae) Extracts and Essential Oil by in Vitro and in Silico Approaches.
    Lobine, Devina
    Pairyanen, Bryan
    Zengin, Gokhan
    Yilmaz, Mustafa Abdullah
    Ouelbani, Rayene
    Bensari, Souheir
    Ak, Gunes
    Abdallah, Hassan H.
    Imran, Muhammad
    Mahomoodally, Mohamad Fawzi
    [J]. CHEMISTRY & BIODIVERSITY, 2021, 18 (04)
  • [44] In silico screening of natural compounds to inhibit interaction of human ACE2 receptor and spike protein of SARS-CoV-2 for the prevention of COVID-19
    Sharma, Priyanka
    Joshi, Tanuja
    Joshi, Tushar
    Mathpal, Shalini
    Maiti, Priyanka
    Nand, Mahesh
    Chandra, Subhash
    Tamta, Sushma
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (02): : 646 - 658
  • [45] Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
    Rolta R.
    Salaria D.
    Sharma P.P.
    Sharma B.
    Kumar V.
    Rathi B.
    Verma M.
    Sourirajan A.
    Baumler D.J.
    Dev K.
    [J]. Current Pharmacology Reports, 2021, 7 (4) : 135 - 149
  • [46] Favipiravir vs. Deferiprone: Tautomeric, photophysical, in vitro biological studies, and binding interactions with SARS-Cov-2-MPro/ACE2
    Tzvetkov, Nikolay T.
    Peeva, Martina, I
    Georgieva, Maya G.
    Deneva, Vera
    Balacheva, Aneliya A.
    Bogdanov, Ivan P.
    Ponticelli, Maria
    Milella, Luigi
    Kirilov, Kiril
    Matin, Maima
    Stammler, Hans -Georg
    Atanasov, Atanas G.
    Antonov, Liudmil
    [J]. CURRENT RESEARCH IN BIOTECHNOLOGY, 2024, 7
  • [47] Elemental Analysis, Phytochemical Screening and Evaluation of Antioxidant, Antibacterial and Anticancer Activity of Pleurotus ostreatus through In Vitro and In Silico Approaches
    Mishra, Vartika
    Tomar, Sarika
    Yadav, Priyanka
    Vishwakarma, Shraddha
    Singh, Mohan Prasad
    [J]. METABOLITES, 2022, 12 (09)
  • [48] The severity of COVID-19 in hypertensive patients is associated with mirSNPs in the 30 UTR of ACE2 that associate with miR-3658: In silico and in vitro studies
    Safdar, Muhammad
    Ozaslan, Mehmet
    Mustafa, Rebaz M.
    Smail, Shukur W.
    Khan, Samiha S.
    Khan, Muhammad Sajjad
    Akhtar, Muhammad Asad
    Ali, Hafiz Khawar
    Younas, Umair
    Saeed, Muhammad
    Siddique, Faisal
    Naveed, Muhammad
    Rehman, SaifUr
    [J]. JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2023, 18 (05): : 1030 - 1047
  • [49] Chemical Composition of Thyme (Thymus vulgaris) Extracts, Potential Inhibition of SARS-CoV-2 Spike Protein-ACE2 Binding and ACE2 Activity, and Radical Scavenging Capacity
    Yao, Yuanhang
    Whent, Monica
    Li, Yanfang
    Liu, Zhihao
    Pehrsson, Pamela
    Sun, Jianghao
    Chen, Pei
    Huang, Dejian
    Wang, Thomas T. Y.
    Wu, Xianli
    Yu, Liangli
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (49) : 19523 - 19530
  • [50] IN SILICO SCREENING OF SHORT CHAIN FATTY ACIDS FROM ALGAE TARGETING ACE2 RECEPTOR FOR SARS-CoV-2: MOLECULAR DOCKING AND MOLECULAR DYNAMICS SIMULATION
    Sayin, Selin
    [J]. FRESENIUS ENVIRONMENTAL BULLETIN, 2021, 30 (05): : 5119 - 5130